In the fall, we will participate in the 19th Czech Annual Cancer Research Meeting, which will take place in Olomouc from November 18 to 20, 2024, at the NH Collection Olomouc Congress Hotel. This pre...
Read moreCome visit us at the Symposium on Biology and Immunology of Reproduction, taking place at the Liblice Castle from October 13th to 15th. We look forward to meeting you after this wonderful summer!
Read moreDescription
The interferons (IFN)s are a family of cytokines with potent antiviral, antitumor, and immunomodulatory properties. Interferons are increasingly used clinically to treat a range of malignancies, myelodysplasias and autoimmune diseases. Interferons are divided into type I, II, and III. Type I IFNs (IFN-α and IFN-β) are most abundant in number, distribution, and expression.
IFN-α1 (interferon α 1) belongs to type 1 interferon family, and is a lymphoid factor. IFN-α1 interacts with IFNAR1 (interferon α receptor 1) and IFNAR2. The interaction activates JAK1 (janus-activated kinase 1) and tyrosine kinase 2. These events phosphorylate and activate STAT1 and STAT2 (signal transducer and activator of transcription proteins), leading to the upregulation of interferon-stimulated genes some of which encode antiviral proteins.
Full Name
Interferon α 1
Source
E. coli
Species
Human
Accession #
J00210
Molecule Weight
The mature recombinant human IFN-α1 is a 19.3kDa protein containing 166 amino acid residues.
Purity
> 95 % as determined by SDS-PAGE
Endotoxin
< 0.1 EU per μg of the protein as determined by the LAL method
Storage
-80 °C, avoid repeated freeze-thaw cycles.
Storage Buffer
PBS